Bryce Dunbar, associate engineer, CMC Icos Biologics
Yvonne Eaton, QC specialist III, Alexion
June Eisenman, founder and board co-chair, Sustainable Path Foundation
Tyler Ellison, president, Pacific Marketing Consultants
Gerald Engley, senior director of medical affairs, ZymoGenetics
Lowell Ericson, board member, Sustainable Path Foundation
Terry Farrah, software engineer, Institute for Systems Biology
Phil Fergusson, director, medical science liaison, ZymoGenetics
Barbara Finck, senior vice president, chief medical officer, NKT Therapeutics
David Fitzpatrick, owner, Biotech Clarity Consulting
Kate Flanders, independent clinical research professional [Added: 2:15 pm PT, 12/5/11]
Chuck Foerder, director, bioanalytical development, Seattle Genetics
Beth Fortmueller, owner, Fortmueller HR Consulting
Alan Frazier, managing partner, Frazier Healthcare Ventures
Eric Frieden, vice president of process science and manufacturing, Axerion Therapeutics
Ed Fritzky, board member, Geron
Victor Fung, executive director, Amgen
Susan Furman, regulatory affairs professional
Laurent Galibert, head of metabolism and inflammation business unit, Addexpharma
Peter Gambacorta, president and CEO, The Learning Retention Company
George Everett Gardipee, supervisor, quality control, lab services, Dendreon
Leslie Garrison, independent pharmaceuticals professional
Richard Gayle, president, SpreadingScience
Richard Ghalie, chief medical officer, HemaQuest Pharmaceuticals
Stephanie Gidlund Feldt, associate director of market planning, Dendreon
Mark Gilbert, biotechnology professional
Randy Gilbert, production lab manager, NanoString Technologies [Added: 10:25 am, 12/29/11]
Steve Gillis, managing director, Arch Venture Partners
Wayne Gombotz, vice president of pharmaceutical operations, Omeros
John Goodleaf, senior systems analyst, Dendreon
Ray Goodwin, co-founder, VLST
